Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
5.47
+0.02 (0.37%)
Jul 21, 2026, 12:36 PM EDT - Market open
Unicycive Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
22
Market Cap
149.84M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 675.00K | -276.00K | -29.02% |
| Dec 31, 2022 | 951.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pyxis Oncology | 13.86M |
| Innate Pharma | 10.57M |
| Cibus | 4.29M |
| Milestone Pharmaceuticals | 1.78M |
| Kazia Therapeutics | 1.27M |
| Molecular Partners AG | 856.30K |
| Connect Biopharma Holdings | 233.00K |
UNCY News
- 20 days ago - Unicycive Therapeutics price target lowered to $50 from $60 at Noble Capital - TheFly
- 20 days ago - Unicycive Therapeutics price target lowered to $13 from $18 at Benchmark - TheFly
- 20 days ago - Johnson Fistel Investigates Unicycive Therapeutics, Inc. (NASDAQ: UNCY) on Behalf of Investors - GlobeNewsWire
- 21 days ago - Unicycive Therapeutics price target lowered to $15 from $22 at H.C. Wainwright - TheFly
- 21 days ago - Unicycive Therapeutics CRL tied to same vendor deficiency, says B. Riley - TheFly
- 21 days ago - Unicycive Therapeutics receives complete response letter from FDA for OLC NDA - TheFly
- 21 days ago - Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA) - GlobeNewsWire
- 4 weeks ago - Unicycive Therapeutics Proxy statement: Proxy filing - Filings